The Safety of Ticagrelor Monotherapy After Primary Percutaneous Coronary Intervention for ST-elevation Myocardial Infarction and the Effect on Intramyocardial Haemorrhage
Condition: ST Elevation Myocardial Infarction Interventions: Drug: Ticagrelor; Drug: Aspirin Sponsor: Radboud University Medical Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials
Evaluate the Efficacy and Safety of Aspirin in Combination With Trametinib and Dabrafenib
Conditions: NSCLC; BRAF V600E Mutation; Advanced Cancer; Stage IIIB NSCLC; Stage IV NSCLC Intervention: Drug: Combind asprin with Trametinib and Dabrafenib Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials
The Safety of Ticagrelor Monotherapy After Primary Percutaneous Coronary Intervention for ST-elevation Myocardial Infarction and the Effect on Intramyocardial Haemorrhage
Condition: ST Elevation Myocardial Infarction Interventions: Drug: Ticagrelor; Drug: Aspirin Sponsor: Radboud University Medical Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials
Evaluate the Efficacy and Safety of Aspirin in Combination With Trametinib and Dabrafenib
Conditions: NSCLC; BRAF V600E Mutation; Advanced Cancer; Stage IIIB NSCLC; Stage IV NSCLC Intervention: Drug: Combind asprin with Trametinib and Dabrafenib Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials
The Safety of Ticagrelor Monotherapy After Primary Percutaneous Coronary Intervention for ST-elevation Myocardial Infarction and the Effect on Intramyocardial Haemorrhage
Condition: ST Elevation Myocardial Infarction Interventions: Drug: Ticagrelor; Drug: Aspirin Sponsor: Radboud University Medical Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials
Evaluate the Efficacy and Safety of Aspirin in Combination With Trametinib and Dabrafenib
Conditions: NSCLC; BRAF V600E Mutation; Advanced Cancer; Stage IIIB NSCLC; Stage IV NSCLC Intervention: Drug: Combind asprin with Trametinib and Dabrafenib Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials
The Safety of Ticagrelor Monotherapy After Primary Percutaneous Coronary Intervention for ST-elevation Myocardial Infarction and the Effect on Intramyocardial Haemorrhage
Condition: ST Elevation Myocardial Infarction Interventions: Drug: Ticagrelor; Drug: Aspirin Sponsor: Radboud University Medical Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials
Evaluate the Efficacy and Safety of Aspirin in Combination With Trametinib and Dabrafenib
Conditions: NSCLC; BRAF V600E Mutation; Advanced Cancer; Stage IIIB NSCLC; Stage IV NSCLC Intervention: Drug: Combind asprin with Trametinib and Dabrafenib Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials
The Safety of Ticagrelor Monotherapy After Primary Percutaneous Coronary Intervention for ST-elevation Myocardial Infarction and the Effect on Intramyocardial Haemorrhage
Condition: ST Elevation Myocardial Infarction Interventions: Drug: Ticagrelor; Drug: Aspirin Sponsor: Radboud University Medical Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials
Evaluate the Efficacy and Safety of Aspirin in Combination With Trametinib and Dabrafenib
Conditions: NSCLC; BRAF V600E Mutation; Advanced Cancer; Stage IIIB NSCLC; Stage IV NSCLC Intervention: Drug: Combind asprin with Trametinib and Dabrafenib Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials
The Safety of Ticagrelor Monotherapy After Primary Percutaneous Coronary Intervention for ST-elevation Myocardial Infarction and the Effect on Intramyocardial Haemorrhage
Condition: ST Elevation Myocardial Infarction Interventions: Drug: Ticagrelor; Drug: Aspirin Sponsor: Radboud University Medical Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials
Evaluate the Efficacy and Safety of Aspirin in Combination With Trametinib and Dabrafenib
Conditions: NSCLC; BRAF V600E Mutation; Advanced Cancer; Stage IIIB NSCLC; Stage IV NSCLC Intervention: Drug: Combind asprin with Trametinib and Dabrafenib Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 11, 2023 Category: Research Source Type: clinical trials
The Safety of Ticagrelor Monotherapy After Primary Percutaneous Coronary Intervention for ST-elevation Myocardial Infarction and the Effect on Intramyocardial Haemorrhage
Condition: ST Elevation Myocardial Infarction Interventions: Drug: Ticagrelor; Drug: Aspirin Sponsor: Radboud University Medical Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 10, 2023 Category: Research Source Type: clinical trials
